Fig. 6. In vivo imaging and cytotoxicity test. (a) Biodistribution of TTVP in HeLa tumor-bearing mice after intratumoral injection of TTVP (10 μM, 20 μL) at different times. (b) Ex vivo fluorescence imaging of various organs and tumor tissue from mice injected with TTVP. The mice were sacrificed at 24 h post-injection. (c) Images of various H&E-stained organ slices from mice.
